Literature DB >> 7350842

Sensitivity and specificity of serum ribonuclease in the diagnosis of pancreatic cancer.

A L Warshaw, K H Lee, W C Wood, A M Cohen.   

Abstract

The serum levels of a poly-[C]-specific acid ribonuclease (RNase) found in the pancreas was measured in 40 normal persons and 137 patients with pancreatic cancer, other cancers, obstructive jaundice, acute pancreatitis or chronic pancreatitis. Serum RNase increased by as much as 800 percent above normal in 69 percent of patients with pancreatic cancer. Analysis of the serum isoenzymes of RNase by isoelectric focusing did not reveal any unique RNases produced by the tumours. In contrast, serum RNase rose in only 8 percent of patients with other cancers, 11 percent of other patients with obstructive jaundice and in no patients with chronic pancreatitis. These data suggest that the finding of increased serum RNase is of adjunctive value inthe diagnosis of pancreatic carcinoma and may be particularly helpful in distinguishing it from other causes of biliary obstruction and from chronic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7350842     DOI: 10.1016/0002-9610(80)90225-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  10 in total

1.  Serum ribonuclease activity in the diagnosis of pancreatic disease.

Authors:  T P Kemmer; P Malfertheiner; M Büchler; M L Kemmer; H Ditschuneit
Journal:  Int J Pancreatol       Date:  1991-01

Review 2.  Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 6. Differentiation between chronic pancreatitis and pancreatic cancer.

Authors:  E J Boyd; H Rinderknecht; K G Wormsley
Journal:  Int J Pancreatol       Date:  1988-05

3.  Serologic markers in the diagnosis and management of pancreatic carcinoma.

Authors:  D K Podolsky
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

4.  Ribonuclease C and pancreatic secretory proteins in the peripheral circulation before and after pancreatectomy for pancreatic cancer.

Authors:  S B Abramson; H Rinderknecht; I G Renner
Journal:  Dig Dis Sci       Date:  1982-10       Impact factor: 3.199

Review 5.  Molecular oncology in pancreatic cancer.

Authors:  S Gansauge; F Gansauge; H G Beger
Journal:  J Mol Med (Berl)       Date:  1996-06       Impact factor: 4.599

6.  CAM 17.1--a new diagnostic marker in pancreatic cancer.

Authors:  F Gansauge; S Gansauge; N Parker; M I Beger; B Poch; K H Link; F Safi; H G Beger
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

7.  Human pancreatic secretory protein profiles in the search for tumor markers.

Authors:  T T White; B J Allan; J J Schilling; H Miyashita
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

8.  Ribonuclease and ribonuclease inhibitor in the human pancreas.

Authors:  H Kiyohara; M Menjo
Journal:  Gastroenterol Jpn       Date:  1983-10

Review 9.  A novel ligand-receptor relationship between families of ribonucleases and receptor tyrosine kinases.

Authors:  Ying-Nai Wang; Heng-Huan Lee; Mien-Chie Hung
Journal:  J Biomed Sci       Date:  2018-11-19       Impact factor: 8.410

10.  Site-specific RNase A activity was dramatically reduced in serum from multiple types of cancer patients.

Authors:  Weiyan Huang; Mei Zhao; Na Wei; Xiaoxia Wang; Huqing Cao; Quan Du; Zicai Liang
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.